Multiple myeloma: The ratio of serum C-terminal telopeptide of collagen type I (CTX-I) and bone-specific alkaline phosphatase (BAP) offers useful clinical information on the risk of progression of osteolytic bone disease

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Original languageEnglish
Publication date2009
Publication statusPublished - 2009
EventDHS's Årsmøde - Middelfart, Denmark
Duration: 20. Mar 200921. Mar 2009

Conference

ConferenceDHS's Årsmøde
CountryDenmark
CityMiddelfart
Period20/03/200921/03/2009

Cite this